drugset

drugset / Trial / NCT05990530

Allogeneic Transplantation of Expanded Pancreatic Islet Cells

NCT05990530 ↗

Phase 2 Unknown 6 enrolled Shanghai Jiao Tong University School of Medicine

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the efficacy and safety of allogeneic pancreatic islet cells transplantation in patients with "brittle" type 1 diabetes.

Timeline

Start: 2023-02-22
Primary completion: 2024-08
Completion: 2025-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	YD02-2022	Cell therapy	—	Other

Indications